Cubist Systematic Strategies, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $24,236 - $34,430	19,235 New	19,235 $32,000
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $641,791 - $1.1 Million	-562,975 Reduced 93.21%	41,000 $76,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $353,438 - $645,025	294,532 Added 95.18%	603,975 $803,000
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $54,085 - $116,797	-33,181 Reduced 9.68%	309,443 $522,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $218,137 - $1.12 Million	298,818 Added 682.14%	342,624 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $96,373 - $183,985	43,806 New	43,806 $104,000
Q1 2022 May 16, 2022	SELL	$2.83 - $8.69 $3.27 Million - $10.1 Million	-1,156,832 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $7.3 Million - $13.1 Million	878,232 Added 315.23%	1,156,832 $9.61 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $2.55 Million - $3.7 Million	278,600 New	278,600 $3.23 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.